GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human galectin-3 crd in complex with 3- fluophenyl-1,2,3-triazolyl thiodigalactoside inhibitor

Analyse Crystal structure of human galectin-3 crd in complex with 3… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5E89
Type
protein
Length
137 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Galectin-3
UniProt
P17931
Ligands
TD2, CL

Structure

x-ray diffraction · 1 distinct chain · 2% helix, 62% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGalectin-3protein1372% helix, 62% strandP17931

Ligands and binding sites

  • TD2 · 3-deoxy-3-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-beta-D-galactopyranosyl 3-deoxy-3-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-1-thio-beta-D-galactopyranoside · ligand · chains A
  • CL · Chloride ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 5E89 · Crystal structure of Human galectin-3 CRD in complex with 3-fluophenyl-1,2,3-triazolyl… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.